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Background: Inflammation within the oral cavity occurs due to dysregulation between microbial biofilms and the
host response. Understanding how different oral hygiene products influence inflammatory properties is important
for the development of new products. Therefore, creation of a robust host-pathogen biofilm platform capable of
evaluating novel oral healthcare compounds is an attractive option. We therefore devised a multi-species biofilm
co-culture model to evaluate the naturally derived polyphenol resveratrol (RSV) and gold standard chlorhexidine
(CHX) with respect to anti-biofilm and anti-inflammatory properties.
Methods: An in vitro multi-species biofilm containing S. mitis, F. nucleatum, P. gingivalis and A. actinomycetemcomitans
was created to represent a disease-associated biofilm and the oral epithelial cell in OKF6-TERT2. Cytotoxicity studies were
performed using RSV and CHX. Multi-species biofilms were either treated with either molecule, or alternatively epithelial
cells were treated with these prior to biofilm co-culture. Biofilm composition was evaluated and inflammatory responses
quantified at a transcriptional and protein level.
Results: CHX was toxic to epithelial cells and multi-species biofilms at concentrations ranging from 0.01-0.2%. RSV did
not effect multi-species biofilm composition, but was toxic to epithelial cells at concentrations greater than 0.01%. In
co-culture, CHX-treated biofilms resulted in down regulation of the inflammatory chemokine IL-8 at both mRNA and
protein level. RSV-treated epithelial cells in co-culture were down-regulated in the release of IL-8 protein, but not
mRNA.
Conclusions: CHX possesses potent bactericidal properties, which may impact downstream inflammatory mediators.
RSV does not appear to have bactericidal properties against multi-species biofilms, however it did appear to supress
epithelial cells from releasing inflammatory mediators. This study demonstrates the potential to understand the
mechanisms by which different oral hygiene products may influence gingival inflammation, thereby validating the use
of a biofilm co-culture model.
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Periodontal disease occurs from a dysregulation between
the bacterial biofilm at the gum margin and the immune
response, resulting in irreversible destruction of both soft
and hard tissues supporting the teeth, ultimately leading to
tooth loss. In health, innate and adaptive immune mole-
cules mediate the equilibrium between the host and the
predominantly Gram positive heterogeneous bacterial sus-
pensions in saliva and adherent biofilm communities on
soft and hard tissue surfaces throughout the oral cavity. In
periodontal disease the shift in the microbiota from Gram
positive to Gram negative species leads to an dysregulated
host response both from local tissues and immune cells
which induces inflammation and creates a niche at the root
for anaerobic species to survive, further exacerbating the
disease [1].
Numerous prokaryote species have been identified within
the oral cavity existing within complex biofilm ecosystems
either as supra- or sub-gingival plaque. Many are unculti-
vated and unnamed, but all playing important structural
and functional roles [2]. Microarray and next generation se-
quencing studies of the oral microbiota has allowed classifi-
cation of some species of bacteria into complexes based on
associations with health and disease [3,4]. These have
allowed studies to investigate species, such as the disease-
associated bacteria Porphyromonas gingivalis, and under-
stand their role in challenging the host response [5].
However, oral biofilms are complex and within these poly-
microbial biofilm structures a myriad of intimate interac-
tions occur, making it difficult to delineate the precise
triggers for the pathogenic outcomes associated with im-
mune dysregulation. Therefore, creating a simplified model
with several of these key pathogens is an attractive propos-
ition to evaluate host-pathogen interactions and test actives
for treatment potential.
Treating periodontal disease is difficult; dentists perform
debridement on teeth, administration of antimicrobial
mouthwashes to target biofilms and in advanced periodon-
titis, surgery. However, successes of treatment are variable
and on an individual basis and suggesting biofilm compos-
ition may influence the outcome of treatment [6]. Anti-
microbial mouthwashes currently employed to manage oral
diseases include a variety of compounds with chlorhexidine
(CHX) being considered the ‘gold standard’ due to its bac-
tericidal and bacteriostatic properties [7]. Additionally,
polyphenols, found naturally occurring in plants such as
grapes have become a focus for oral therapies due to their
anti-inflammatory and anti-bacterial properties [8]. Resver-
atrol (RSV) is a naturally derived polyphenol, which has
been shown to have potent anti-inflammatory properties in
a variety of cancer cells and recently periodontitis in rats
[9,10].
Both CHX and RSV have desirable properties for
periodontitis prevention, being antimicrobial or anti-inflammatory and antimicrobial, respectively. The pur-
pose of this study was therefore to create and validate a
multi-species biofilm model to be used in co-culture
with host epithelial cells in order to test the actives
CHX and RSV in order to validate whether the model sys-
tem could be used as a sensitive method of delineating their
basic modes of action. Here we report that oral epithelial
cells produce a reproducible pro-inflammatory response to
our multi-species biofilm at both gene and protein level.
Additionally the treatment of either epithelial cells or
multi-species biofilms with actives resulted in an alteration
of inflammation within the co-culture model.
Methods
Growth and standardisation of bacteria
Porphyromonas gingivalis ATCC 33277, Fusobacterium
nucleatum ATCC 10953, Aggregatibacter actinomycetemco-
mitans ATCC 43718 and Streptococcus mitis ATCC 12261
were used in the course of these studies. P. gingivalis ATCC
33277 and F. nucleatum ATCC 10596 were grown at 37°C
in Schaedler anaerobe broth (Oxoid, Cambridge, UK) for
2 days and 1 day, respectively, in an anaerobic chamber
(85% N2, 10% CO2 and 5% H2, [Don Whitley Scientific
Limited, Shipley, UK]). A. actinomycetemcomitans ATCC
43718 and Streptococcus mitis ATCC 12261 were grown at
37°C in tryptic soy broth (Sigma, Poole, UK) supplemented
with 0.8% w/v glucose (BDH, Poole, UK) and 0.6% w/v
yeast extract (Oxoid, Cambridge, UK) for 1 day in 5% CO2.
The bacteria were washed with PBS then standardized to
an OD550 of 0.2, except for S. mitis, which was standardized
to an OD550 of 0.5, in a colorimeter to obtain approximately
1 × 108 cfu/mL of each bacterial species on their specified
day of use.
Active compounds
Chlorhexidine (CHX [Sigma]) and resveratrol (RSV
[Sigma]) were used throughout this study. CHX solution
was prepared at 0.01, 0.05 and 0.2% v/v in keratinocyte
serum free media (KSFM) and used for subsequent anti-
microbial testing. RSV powder was solubilised in ddH2O
prior to preparation in KSFM at 0.01, 0.05 and 0.5% v/v
and used for subsequent cell stimulation studies.
Development of multi-species biofilms
Bacteria were standardized (1 × 107 cfu/mL) in artificial sal-
iva (AS), which contained the following constituents, as de-
scribed previously [11]. This included porcine stomach
mucins (0.25% w/v), sodium chloride (0.35 w/v), potassium
chloride (0.02 w/v), calcium chloride dihydrate (0.02 w/v),
yeast extract (0.2 w/v), lab lemco powder (0.1 w/v), prote-
ose peptone (0.5 w/v) in ddH2O (Sigma, Poole, UK). Urea
was then added to independently to a final concentration of
0.05% (v/v). To initiate multispecies biofilm development
the pioneer species S. mitis biofilm were first formed for
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slips within 24 well plates (Corning, NY, USA). The super-
natant was then removed and F. nucleatum added, which
was incubated anaerobically at 37°C for a further 24 h. The
supernatant was removed and P. gingivalis and A. actino-
mycetemcomitans added to the dual species biofilm, which
was incubated anaerobically at 37°C for a further 4 days, re-
placing the AS daily to produce a mixed four species bio-
film (Figure 1A).A
B
Figure 1 Development of multi-species biofilm co-culture model. A. M
placed in 24 well plates for biofilm culture. Bacteria were grown on approp
washed three times in PBS and standardized at 1×109 CFU/ ml, added to a
biofilm on the appropriate days and cultured in aerobic and anaerobic con
biofilms which are then washed with PBS and stored at −80°C. B. Hanging
Thermanox™ coverslips and previously described. Epithelial cells (OKF6-TER
media. Biofilms were attached inversely to Millipore cell culture inserts usin
were co-cultured for 4 and 24 h.Quantitative analysis of biofilm composition
Real-time quantitative PCR (qPCR) was then performed
to enumerate the definitive and relative composition of
the biofilms. Briefly, bacterial biofilms were removed by
sonication in a sonic bath at 35 kHz for 10 min, as
previously described [12]. For qPCR the biofilm sonicate
was used for DNA extraction using the MasterPure
Gram Positive DNA Purificiation Kit (Epicentre®,
Cambridge, UK), following manufacturers instructions,ulti-species biofilm culture protocol. Thermanox™ coverslips were
riate agar plates and cultured in broth for 1–2 days. Cultures were then
rtificial saliva to make a 1×108 CFU/ml final volume and added to the
ditions. After 7 days culture artificial saliva is removed from mature
basket co-culture model. Multi-species biofilms were grown on
T2) were seeded in 24 well plates at 1×105 cells/ml in cell culture
g Vaseline® and placed over wells containing cells. Cells and biofilms
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for 4 h to ensure cell lysis. The extracted DNA under-
went quality checks using the NanoDrop spectropho-
tometer (Fischer Scientific, Loughborough). Briefly, 1 μL
of extracted DNA was added to a mastermix containing
12.5 μL SYBR® GreenER™, 9.5 μL UV-treated RNase-free
water and 1 μL of 10 μM forward/reverse primers for
each bacterial species. The primers used were previously
published, as listed in Table 1. Three independent repli-
cates from each parameter were analysed in triplicate
using MxProP Quantitative PCR machine and MxProP
3000 software (Stratagene, Amsterdam, Netherlands).
Samples were quantified to calculate the colony forming
equivalent (CFE) based upon a previously established
standard curve of bacterial colony forming units ranging
from 1 × 103 to 108 cfu/mL. The R2 values for these
standard curves ranged from 0.956 to 0.994. Melting
curve analysis was performed for all primer sets to en-
sure a single peak, which was indicative of primer speci-
ficity. Biofilm architecture was subsequently analysed by
scanning electron microscopy (SEM). For this biofilm
specimens were washed in PBS, fixed in 2% para-
formaldehyde, 2% gluteraldehyde, 0.15% w/v Alcian Blue
in 0.15 M sodium cacodylate (pH 7.4) [13]. The fixed
and dried samples were sputter-coated with gold and
viewed under a JEOL JSM-6400 scanning electron
microscope [14].
Development of an epithelial biofilm co-culture model
OKF6-TERT2 cells (kind gift of the Rheinwald laboratory,
Brigham and Woman’s Hospital, Boston) are an immortal-
ized human oral keratinocyte cell line [20] was used
throughout these investigations. OKF6 cells were cultured
in keratinocyte serum-free medium (KSFM) as previously
described [21]. At 90% confluence the cells were trypsi-
nised, washed in Hanks balanced salt solution then re-
seeded to approximately 1 × 105 cells/mL and seeded onto
a Thermanox™ coverslip within a 24 well cell culture plate
(Corning, NY, USA). The epithelial cells were washed and
then subject to challenge with inverted biofilms, attached
using Vaseline® to hanging cell culture inserts (Millipore,Table 1 Primers used for qPCR in this study
Gene Forward 5′-3′
Cytokine
IL-8 CAGAGACAGCAGAGCACACAA
GAPDH CAAGGCTGAGAACGGGAAG
Bacterial species
S. mitis GATACATAGCCGACCTGAG
F. nucleatum GGATTTATTGGGCGTAAAGC
P. gingivalis GCGCTCAACGTTCAGCC
A. actinomycetemcomitans GAACCTTACCTACTCTTGACATCCGAAMA, USA) as illustrated in Figure 1B. The biofilms on the
Thermanox™ discs were separated from the epithelial cells
on the bottom of the well by a small space of <0.5 mm, rep-
resentative of a gingival crevice. Multispecies biofilms were
incubated in the co-culture model for 4 and 24 h and the
viability of the epithelial cells ± active treatments (CHX and
RSV) evaluated using a metabolic assay of 10% v/v alamar-
Blue®, according to the manufacturer’s instructions (Life
Technologies, Paisley, UK). After 4 h incubation the ab-
sorbance was read at 570 nm and the reference wavelength
at 600 nm, and the percentage reduction in biofilm viability
calculated using the manufacturer’s formula.
Assessing inflammatory changes during biofilm co-culture
Supernatants and cell lysates were collected from OKF6/
TERT2 cells stimulated with different multispecies biofilms,
which were used for protein and transcriptional analysis,
respectively, to assess the regulation of pro-inflammatory
mediators. Initial gene expression analysis was carried out
using a custom designed RT2 Profiler PCR Array (Qiagen,
Crawley, UK). RT2 Profiler arrays are a SYBR® GreenER™
based real-time PCR that allow for the detection of several
genes of interest, simultaneously. Briefly, RNA was ex-
tracted from cell lysates (Qiagen, Crawley, UK) and 55 ng/
μl of cDNA synthesised using the RT2 First Strand cDNA
synthesis kit (Qiagen, Crawley, UK), as per manufacturers
instructions. Briefly, 24 μl of a mastermix containing SYBR®
GreenER™, cDNA synthesised using the RT2 First Strand
kit (Qiagen) and RNase-free water was added to each well
of the RT2 Profiler plate, which already contained the for-
ward and reverse primers for the genes of interest (IL-1α,
IL-1β, IL-6, TNF, CSF2, CSF3, IL-8, CXCL1, CXCL3,
CXCL5, CCL1 and GAPDH), based on an experimental
gingivitis model [22]. Two replicates of each condition were
used in the RT2 Profiler, which was carried out on two sep-
arate occasions.
Further verification was performed using IL-8 gene ex-
pression analysed using SYBR® Green based qPCR (Invi-
trogen), using GAPDH as a housekeeping gene. Primer
sequences and reference sources are listed in Table 1.
All primers were tested against each bacterial species toReverse 5′-3′ Reference
TTAGCACTCCTTGGCAAAAC [15]
GGTGGTGAAGACGCCAGT [15]
CCATTGCCGAAGATTCC [16]
GGCATTCCTACAAATATCTACGAA [17]
CACGAATTCGCCTGC [18]
TGCAGCACCTGTCTCAAAGC [19]
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RNA was synthesised into cDNA then added to a
mastermix containing 12.5 μl SYBR® GreenER™, 10.5 μl
UV-treated RNase-free water and 0.5 μl of forward/re-
verse primers. Three independent replicates from each
parameter were analysed in duplicate using MxProP
Quantitative PCR machine and MxProP 3000 software
(Stratagene, Amsterdam, Netherlands) and gene expres-
sion normalised to the housekeeping gene GAPDH ac-
cording to the 2-ΔΔCT method [23]. IL-8 release into cell
culture supernatants was assessed by ELISA (Invitrogen,
Paisley, UK), as per manufacturer’s instructions. Results
were calculated using a 4-parameter curve fit, quantify-
ing colometric changes at 630 nm (BMG-Labtech,
Ortenberg, Germany).
Statistical analysis
Graph production, data distribution and statistical analysis
were performed using GraphPad Prism (version 4; La
Jolla, CA, USA). After assessing whether data conformed
to a normal distribution by before and after data trans-
forms, One-way Analysis of Variance (ANOVA) and t
tests were used to investigate significant differencesFigure 2 Analysis of multi-species biofilms in anaerobic and aerobic c
in 24 well plates for 6 days as previously described. After maturation DNA wa
quantification of each species using SYBR® GreenER™ based qPCR (A). Biofilm
were processed and viewed on a JEOL JSM-6400 scanning electron microsco
seen to be complex (B). At higher magnifications different morphologies can
the biofilm (C). Mature biofilms were also cultured in cell culture media in 5%
species using using SYBR® GreenER™ based qPCR (D). All samples were assayebetween independent groups of data that approximated to
a Gaussian distribution. A Bonferroni correction was ap-
plied to the p value to account for multiple comparisons
of the data. Non-parametric data was analysed using the
Mann–Whitney U-test to assess differences between two
independent sample groups. Student t-tests were used to
measure statistical differences between the ΔCt values of
the two independent groups assessed in gene expression
studies, although data may be represented as percentage
or fold change in the figures. Statistical significance was
achieved if P < 0.05.
Results
Quantitative analysis of a multi-species periodontal
biofilm model
Sonicated multi-species biofilms were quantified by
qPCR (Figure 2A). It was shown that quantitatively that
S. mitis was the most dominant species within the ma-
ture biofilm (1.36 × 107 CFE/mL; 83.24%), followed by F.
nucleatum (2.28 × 106; 15.16%), P. gingivalis (3.53 ×10 4;
1.01%) and A. actinomycetemcomitans (1.13 × 105;
0.58%). The biofilm composition was then examined
using SEM analysis. The biofilm was shown to be aonditions. Multi-species biofilm were grown on Thermanox™ coverslips
s extracted using Masterpure™ Gram-positive DNA purification kit for
morphology was analyzed by SEM at 2000x (B) and 5000x (C). Samples
pe and images assembled using Photoshop software. Biofilms can be
be identified with S. mitis and F. nucleatum making up the majority of
CO2 for 4 and 24 h before DNA extraction and quantification of each
d in triplicate on three separate occasions. Data are mean ± SD.
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F. nucleatum (Figure 2B and C).
In order to test the multi-species biofilms in co-culture
with epithelial cells, we examined the impact of moving the
biofilm from anaerobic conditions within AS to 5% CO2 in
KSFM. To do this we evaluated the biofilm composition as
described above. No significant differences were observed
in the composition and quantity of the 4 species within the
CO2 biofilm at 4 and 24 h (Figure 2D). There was also no
significant difference between 24 h biofilms formed under
anaerobic conditions and those then placed in CO2 for a
further 24 h. These biofilms were then used in a co-culture
system to investigate the biological properties of two differ-
ent bioactive agents.
Investigating the effects of bioactive agents in a
multi-species biofilm epithelial cell co-culture model
First, to optimise the concentrations of RSV and CHX to
be tested in this model we undertook cytoxicity tests on
both epithelial cells and on biofilms.
Oral epithelial cells were treated for 30 min with three
concentration of the antimicrobial active CHX (0.01, 0.05,
0.2% v/v) and anti-inflammatory active RSV (0.01, 0.05,
0.5% w/v) before washing with PBS and incubated for 4
and 24 h before cell viability was measured assessed using
an AlamarBlue® assay. The data showed a significant de-
crease (p < 0.001) in cell viability compared to the untreated
media controls when epithelial cells are incubated with
CHX at any concentration for both 4 and 24 h (Figure 3A).
When epithelial cells were co-cultured with RSV significant
decreases in cell viability compared with the media control
were observed using 0.05 and 0.5% w/v RSV concentrations
at both 4 (p < 0.001) and 24 h (p < 0.01), with an approxi-
mately 50% decrease in cell viability at each time
(Figure 3B).
Next, from these data the concentrations taken for-
ward for the remainder of the study were 0.2% v/v CHX
and 0.01% w/v RSV. Multi-species biofilms were treated
with the chosen concentrations of actives for 30 min
and biofilm viability measured using an AlamarBlue®
assay (Figure 3C). Treatment of the multi-species biofilm
with RSV did not significantly affect biofilm viability
compared to the untreated biofilm control. However,
treatment with CHX showed a significant reduction (p <
0.001) of 75% in bacteria viability compared with the un-
treated biofilm.
To determine if treatment with these actives altered
the species composition of the biofilm, they were treated
for 30 min then DNA extracted and quantification of
each species performed by qPCR (Figure 3D). The data
show no significant change in the composition following
a 30 min treatment with CHX or RSV compared with
the untreated biofilm. To further investigate this effect
SEM analysis was performed to examine the impact ofeach active on the architecture of the biofilms post-
treatment (Figure 3E-J). CHX appeared to destabilise the
biofilm, as the complexity of the biofilm was reduced,
whereas RSV appeared to have no visual effect on
architecture.
Next, we evaluated the effects of the untreated multi-
species biofilm stimulated OKF6 cells to ensure the biofilm
induced inflammatory mediators. Using the RT2 Profiler we
compared biofilm stimulated cells to media control cells
after 4 h to determine the inflammatory characteristics of
the model (Table 2). Significant increases were observed for
all the genes upon the RT2 profiler selected based on their
expression during induced experimental gingivitis in hu-
man subjects, ranging from 4.39 fold change (CCL1) to
249.8 fold change (IL-8), with an mean fold change of 60
compared to the unstimulated media control. These data
were verified by investigating IL-8 using specific primers
within a reverse transcriptase (RT) qPCR assay (Figure 4B).
A significant increased was observed of a 15.57 fold change
(p < 0.001) after 4 h and 312.88 fold change (p < 0.001) after
24 h when compared to the media control (Table 2). Fi-
nally, we evaluated the cell supernatants for the release of
IL-8 within this system, where it was shown that after 4 h
(535 ng) and 24 h (450 ng) that IL-8 release was signifi-
cantly increased (p < 0.001) compared to the untreated
media controls (Figure 4C). Based on this collective data,
we have demonstrated that the 4-species biofilm has repro-
ducible inflammatory properties within an epithelial co-
culture model.
We then determined how CHX treatment of the biofilm
affected inflammation. The co-culture model was utilised
with biofilms treated with 0.2% CHX for 30 min. Following
co-culture epithelial cell lysates and supernatants were re-
moved to be tested for increased gene and protein inflam-
matory markers. An untreated biofilm and epithelial cells
not co-cultured with the multi-species biofilm were used as
controls. After 4 h co-stimulation with the CHX treated
biofilms we showed no significant difference in gene ex-
pression using the RT2 profiler, though IL-8 and CXCL1
were notably decreased (Figure 4A). Further analysis of IL-
8 using qPCR again showed no significant difference in ex-
pression at 4 h, whereas at 24 h a significant decrease of
5.65 fold was observed in the CHX treated biofilm stimu-
lated cells (p > 0.001) (Figure 4B). IL-8 protein expression
was also measured at 4 and 24 h by ELISA. A significant re-
duction (p < 0.001) of IL-8 protein was observed at 4 h (10
fold) and at 24 h (13 fold) when compared to the untreated
control (Figure 4C).
Finally, we evaluated the effect of RSV treated epithe-
lial cells in the co-culture model. Epithelial cells were
treated for 30 min with RSV, washed and co-incubated
with untreated biofilms for 4 and 24 h. The RT2 profiler
showed no significant differences in gene expression
after 4 h compared with untreated biofilms (Figure 4A).
Figure 3 (See legend on next page.)
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Figure 3 Direct effect of actives on oral epithelial cells and multi-species biofilms. The oral epithelial cell line OKF6-TERT2 was seeded at 1×105 cells/
ml in 24 well plates for toxicity studies. Cells were treated with concentrations of CHX (0.01, 0.05, 0.2% v/v) (A) and RSV (0.01, 0.05, 0.5% w/v) (B) for
30 minutes before washing with PBS. Cell viability was assessed using the Alamarblue® assay with absorbance read at 570 nm and 600 nm. Following this
concentrations chosen for the remainder of the study were CHX 0.2% (v/v) and RSV 0.01% (w/v). To investigate the role of actives in biofilm treatment
biofilms were grown on coverslips in 24 well plates for 6 days as previously described. Mature biofilms were treated with 0.2% v/v CHX and 0.01% w/v RSV
for 30 minutes before washing with PBS. Biofilm viability was measured using Alamarblue® read at 570 nm and 600 nm (C). Bacterial DNA was extracted
and each species quantified using SYBR® GreenER™ based qPCR (D). Biofilms were also analyzed by SEM at both 2000x (E, G, I) and 5000× (F, H, J).
Samples were processed and viewed on a JEOL JSM-6400 scanning electron microscope and images assembled using Photoshop software. Untreated
biofilms (E, F) were compared with biofilms treated with 0.2% (v/v) CHX (G, H) and and 0.01% (w/v) RSV (I, J). Samples were assayed in triplicate on three
separate occasions and data are mean ± SD (**p < 0.01, ***p < 0.001).
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significant differences in expression levels (Figure 4B).
However, a significant decrease in IL-8 protein levels at
4 h (25 fold; p < 0.001) and 24 h (13 fold; p < 0.01) were
observed when compared to the untreated biofilm co-
culture model (Figure 4C).
Discussion
Using experimental in vitro biofilm models to investigate
interactions between biofilms and host epithelial cells is
essential to understanding the mechanisms of disease
pathology and how actives can influence the host re-
sponse. Using this bespoke multi-species biofilm model
we have demonstrated that the epithelial inflammatory
response to multi-species biofilms can be altered in
the presence of antimicrobial and anti-inflammatory
compounds.
The data show co-culture of epithelial cells and un-
treated multi-species biofilms produce a significant in-
crease in both gene and protein expression at 4 and
24 h. IL-8 protein levels were significantly increased at
both 4 and 24 h in co-culture of epithelial cells and un-
treated multi-species biofilms compared with the cells
only control. Additionally, increases in gene expression
of a variety of pro-inflammatory chemokines and cyto-
kines including IL-6, IL-8, TNF, CSF-2, CXCL1 and
CXCL3 at 4 h compared with the cells only control wereTable 2 Pro-inflammatory response to untreated biofilms
Gene Average fold increase SD (±) Significance
IL-1 10.820 8.918 p < 0.05
IL-1B 12.662 1.161 p < 0.05
IL-6 31.876 2.366 p < 0.001
TNF 48.821 24.623 p < 0.001
CSF-2 59.200 28.294 p < 0.001
CSF-3 43.331 37.126 P < 0.001
IL-8 249.805 189.93 p < 0.001
CXCL1 121.892 56.676 p < 0.001
CXCL3 63.843 26.213 p < 0.001
CXCL5 14.435 14.474 n/s
CCL1 4.397 4.629 n/sobserved. These dynamic changes in pro-inflammatory
mediators demonstrate that there is interplay between
the complex biofilm and the epithelial cells. Notably, at
24 h the RNA quality from the co-culture model was
poor and therefore not used to test gene expression
using the RT2 profiler assay, however IL-8 was able to
be measured at 24 h using SYBR® GreenER™ based
qPCR, and was significantly increased compared to
media controls. Pro-inflammatory responses by epithe-
lial cells after challenge with oral biofilms have been
previously reported using a variety of oral associated
bacteria [24,25]. Recently, it has been shown that bio-
films including the ‘red complex’ organisms such as P.
gingivalis or F. nucleatum increased IL-8 production
during early host interaction, yet with longer exposure
the chemotactic factors are downregulated, presumably
through the release of proteolytic gingipains [25]. These
studies also highlight the essential role of studying epi-
thelial responses to bacteria in a biofilm model com-
pared with planktonic bacteria and suggest biofilms
behave differently to their single species counterparts,
which may be in part due to the complex biofilm inter-
action that occur in a microbial community [26].
We have also demonstrated how antimicrobial and
anti-inflammatory actives can influence the host re-
sponse in this co-culture model. CHX while a potent
antimicrobial, also has a high toxicity level when used to
treat epithelial cells and in this study it was therefore de-
cided to treat the biofilms with CHX before co-culture.
Our data show that biofilms treated for 30 min with
CHX have significantly decreased bacterial viability.
However, differences were observed between the quanti-
tative analysis of the biofilm composition by qPCR and
SEM after 30 min treatment with CHX. These are most
likely due to the substantivity of CHX where straight
after treatment bacteria are dead but not dissociated
from the biofilm, which is shown in the qPCR compos-
ition. After treatment and 4 h co-culture images by SEM
show the biofilm is less complex which may be due to
the loss of the dead bacteria from the biofilm as the ef-
fects of CHX decrease over time. This data agrees with
previous work of the mechanisms of action of CHX
which show an immediate bacteriocidal action combined
Figure 4 CHX and RSV immunomodulate epithelial cell responses to multi-species biofilm co-culture in vitro. The oral epithelial cell line
OKF6-TERT2 was seeded at 1×105 cells/ml in 24 well plates for co-culture with multi-species biofilms. Biofilm were pre treated with 0.2% (v/v)
CHX or cells were treated with 0.01% (w/v) RSV for 30 minutes before washing with PBS and then co-cultured with untreated biofilms or cells
respectively for 4 and 24 h. Untreated control co-culture were also included. RNA was extracted from the cell lysates at 4 h, cDNA was synthesized
and pro-inflammatory gene expression quantified on an RT2 profiler plate (A). Duplicate samples from three independent experiments were used
and data are mean ± SD relative to media control. Samples were also assayed for IL-8 relative to housekeeping gene GAPDH at 4 and 24 h using
using SYBR® GreenER™ based qPCR (B). Supernatants were also analyzed for exogenous IL-8, measured by ELISA (C). Samples were assayed in
triplicate from three independent experiments, data are mean ± SD (**p < 0.01, ***p < 0.001).
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of the active to the surface [27]. Epithelial cells co-
cultured with CHX treated multi-species biofilms did
not show a significant change in overall gene expression
at 4 h but a significant decrease in IL-8 levels was ob-
served at 24 h. However, many of the other pro-
inflammatory molecules did tend to decrease at 4 h,
such as IL-6 and IL-1β, though increased others such as
CCL1. Levels of IL-8 protein were significantly de-
creased at both 4 and 24 h. Clinical data of studies using
CHX mouthwashes show significant reductions in in-
flammation following CHX treatment than control
groups [28]. This suggests that reduction in inflamma-
tory markers may be time dependent and linked to the
disaggregation of dead bacteria from the surface of the
biofilm, though the release of bacterial products may in-
advertently activate other pathways.
Testing the anti-inflammatory active RSV we observed
no significant decrease in biofilm viability or epithelial
cell viability at 0.01%. However a significant decrease in
epithelial cell viability was observed at concentrations of
0.05% and 0.5%. RSV has been reported to have anti-
microbial effects both against planktonic and bacterial
biofilms, with most studies focusing on bacteria such as
P. aeruginosa and E. coli with MIC ranging from 5-
50 μg/ml [29,30]. There are no previous studies investi-
gating the toxicity of RSV on epithelial cells. However.
studies have shown RSV induces apoptosis in cancer cell
lines at 0.1-0.3% [31]. Epithelial cells treated with RSV
and co-cultured with multi-species biofilms showed no
significant differences in overall gene expression com-
pared with the untreated controls, though CXCL5, the
neutrophil activating peptide was decreased transcrip-
tionally, which may be involved in reducing neutrophil
activation [32]. Moreover, a significant decrease in IL-8
protein expression was observed at 4 and 24 h compared
with the untreated control. This suggests that RSV may
disrupt the signalling pathway and result in reduced che-
mokine and cytokine production. A variety of studies in-
vestigating the role of RSV and inflammation have found
RSV modulates a variety of cell responses by interfering
with signalling pathways [33,34]. With regards to our
own work previous studies have reported RSV modu-
lates pro-inflammatory responses by modulating NF-κB
and AP-1 [35,36].
Conclusions
This study has investigated the inflammatory response
by epithelial cells to oral biofilms in co-culture and how
actives can mediate this response. We have shown that
multi-species biofilm treatment with the antimicrobial
CHX is able to reduce inflammation produced by epithe-
lial cells at both a gene and protein level. Treatment of
epithelial cells with the anti-inflammatory compoundRSV results in a reduction of epithelial cell inflammation
at protein level. Although the main limitation of this
model may be the number of species within the biofilm
consortium, this does allow more control and reproduci-
bility in the model. However, increasing the complexity
of this model is subject to further work by our group.
Collectively, this work supports the generation of a vali-
dated multi-species periodontal biofilm model suitable
for use in the screening and testing of potential oral hy-
giene actives.
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